Analysts Set The Joint Corp. (NASDAQ:JYNT) Price Target at $22.00

The Joint Corp. (NASDAQ:JYNT) has received an average rating of “Moderate Buy” from the four analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $22.00.

JYNT has been the topic of a number of research reports. TheStreet cut Joint from a “c-” rating to a “d” rating in a research report on Thursday, March 7th. B. Riley increased their target price on Joint from $12.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, May 6th. StockNews.com upgraded Joint from a “hold” rating to a “buy” rating in a research note on Monday, May 6th. Finally, Roth Mkm restated a “buy” rating and set a $16.00 price target (up previously from $13.00) on shares of Joint in a research report on Friday, May 3rd.

Joint Price Performance

JYNT stock opened at $13.20 on Tuesday. The firm has a fifty day moving average price of $14.85 and a two-hundred day moving average price of $12.10. Joint has a 1-year low of $7.31 and a 1-year high of $17.82. The firm has a market cap of $197.60 million, a price-to-earnings ratio of -17.60 and a beta of 1.60.

Joint (NASDAQ:JYNT) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.09. The business had revenue of $29.72 million during the quarter, compared to the consensus estimate of $29.17 million. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%. As a group, analysts expect that Joint will post 0.2 EPS for the current fiscal year.

Institutional Trading of Joint

A number of institutional investors have recently bought and sold shares of the company. First Foundation Advisors acquired a new position in shares of Joint during the 3rd quarter worth $1,336,000. Skylands Capital LLC lifted its position in shares of Joint by 20.3% in the fourth quarter. Skylands Capital LLC now owns 603,640 shares of the company’s stock worth $5,801,000 after buying an additional 101,850 shares during the last quarter. Hudson Bay Capital Management LP bought a new stake in shares of Joint during the 3rd quarter worth about $867,000. Russell Investments Group Ltd. bought a new stake in Joint during the fourth quarter valued at about $795,000. Finally, Sierra Summit Advisors LLC bought a new stake in shares of Joint in the fourth quarter valued at approximately $652,000. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.